Ifosfamide/carboplatin/etoposide (ICE), an effective salvaging therapy for recurrent malignant non-Hodgkin lymphoma of childhood: a Pediatric Oncology Group phase II study

Med Pediatr Oncol. 1999 Mar;32(3):225-6. doi: 10.1002/(sici)1096-911x(199903)32:3<225::aid-mpo12>3.0.co;2-n.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child
  • Child, Preschool
  • Cisplatin / administration & dosage
  • Drug Administration Schedule
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Ifosfamide / administration & dosage
  • Infusions, Intravenous
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Male
  • Neoplasm Recurrence, Local / drug therapy*
  • Salvage Therapy

Substances

  • Etoposide
  • Cisplatin
  • Ifosfamide

Supplementary concepts

  • ICE protocol 1